Abstract:ABSTRACT Discs large membrane-associated guanylate kinase (MAGUK) scaffold protein 1 (DLG1) plays important roles in cell contact and migration, but its role in antiviral innate immunity is not clear. In this study, the role of DLG1 in the antiviral innate immune response and its impact on type-I interferon (IFN-I) signaling were investigated. DLG1 plays a critical role in promoting the IFN-I response by inhibiting the autophagic degradation of the innate immune adaptor IκB kinase epsilon (IKKε). As a result, DLG1 effectively suppresses negative-stranded RNA virus replication, including that of viruses such as vesicular stomatitis virus, Sendai virus, and bovine ephemeral fever virus. DLG1 was found to enhance the production of IFN-β and IFN-stimulated genes, leading to the attenuation of virus propagation. Mechanistically, DLG1 competitively binds to the E3 ubiquitin ligase March2, preventing the ubiquitination and subsequent degradation of IKKε. Notably, March2 specifically catalyzes K27-linked polyubiquitination of IKKε. The interaction between March2 and IKKε is mediated by the transmembrane domain of March2 and the C-terminal domain of IKKε. Furthermore, p62 acts as a cargo receptor, recognizing ubiquitinated IKKε for eventual autophagic degradation, whereas the process is blocked by DLG1. Additionally, the results demonstrated a significant decrease in DLG1 mRNA and protein levels upon negative-stranded RNA virus infection. Overall, these findings provide insights into the molecular mechanisms by which DLG1 promotes IFN-I production by regulating IKKε expression to inhibit viral replication. IMPORTANCE The type-I interferon (IFN-I) signaling pathway is the first line of antiviral innate immunity. It must be precisely regulated against virus-induced damage. The tightly regulated mechanisms of action of host genes in the antiviral innate immune signaling pathway are still worth studying. Here, we report a novel role of DLG1 in positively regulating the IκB kinase epsilon (IKKε)-mediated IFN-I signaling response against negative-stranded RNA virus replication, whereas the RNA virus inhibits the expression of DLG1 for immune escape. Importantly, the E3 ligase March2 interacts with and promotes K27-linked polyubiquitination of IKKε, and p62 is a cargo receptor that recognizes ubiquitinated IKKε for eventual autophagic degradation. Together, the current findings elucidate the role of DLG1 in the antiviral IFN-I signaling pathway and viral infection repression.

The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

The Mitochondrial Proteins NLRX1 and TUFM Form a Complex That Regulates Type I Interferon and Autophagy.

LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I

TNFAIP8L2/TIPE2 Impairs Autolysosome Reformation Via Modulating the RAC1-MTORC1 Axis.

NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function

Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression

Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells.

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

Selective autophagy controls the stability of TBK1 via NEDD4 to balance host defense

LTN1 promotes RLR degradation to inhibit immune response to RNA virus through the ESCRT pathway

Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis

NLRX1 can counteract innate immune response induced by an external stimulus favoring HBV infection by competitive inhibition of MAVS-RLRs signaling in HepG2-NTCP cells

TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy

Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells

Lipopolysaccharide promotes NLRP3 inflammasome activation by inhibiting TFEB-mediated autophagy in NRK-52E cells

DLG1 promotes the antiviral innate immune response by inhibiting p62-mediated autophagic degradation of IKKε